Sarisa-image.jpg

Sarisa is developing a bi-functional inhibitor targeting a host of indications including cancer, fibrotic and inflammatory diseases. Sarisa is currently collaborating with several medical institutions to optimize the efficacy and safety of its lead clinical candidate